Analysts Set Metro, Inc. (MRU) Target Price at $46.44

Shares of Metro, Inc. (TSE:MRU) have been assigned a consensus recommendation of “Hold” from the nine ratings firms that are covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 1 year price objective among analysts that have updated their coverage on the stock in the last year is C$46.44.

Several equities analysts have recently issued reports on the company. Raymond James reduced their target price on Metro from C$47.00 to C$46.00 and set an “outperform” rating for the company in a report on Thursday, August 16th. BMO Capital Markets reaffirmed an “outperform” rating and issued a C$48.00 target price on shares of Metro in a report on Thursday, August 16th.

MRU stock traded down C$0.19 during trading on Friday, reaching C$40.46. 317,011 shares of the stock were exchanged, compared to its average volume of 484,968. Metro has a twelve month low of C$38.32 and a twelve month high of C$45.44.

Metro (TSE:MRU) last issued its quarterly earnings data on Wednesday, August 15th. The company reported C$0.75 EPS for the quarter, missing the consensus estimate of C$0.76 by C($0.01). The company had revenue of C$4.64 billion during the quarter. Metro had a return on equity of 158.77% and a net margin of 41.75%.

Metro Company Profile

Metro Inc operates as a retailer and distributor in the food and pharmaceutical sectors in Canada. It operates supermarkets, discount and drug stores, and food stores that provide grocery products, general merchandise, non-perishable goods, dairy products, prepared meals, fruits and vegetables, meats, and frozen foods.

Recommended Story: How to Invest in Marijuana Stocks

Analyst Recommendations for Metro (TSE:MRU)

Receive News & Ratings for Metro Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metro and related companies with's FREE daily email newsletter.

Leave a Reply